Stockholm3 outperforms PSA for detecting significant prostate cancer
1. In this randomized screening trial, the multivariable Stockholm3 test provided greater clinical net benefit and substantially fewer false-negative results ...
Tag: prostate cancer
Pfizer’s Talzenna combo significantly delays prostate cancer progression
1. The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic progression-free survival for metastatic hormone-sensitive prostate ...
![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-350x250.png)
2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]
Pfizer’s Talzenna combo significantly delays progression in frontline prostate cancer Topline results from the Phase 3 TALAPRO-3 study indicate that ...
New model enhances prediction of prostate cancer-specific mortality
1. In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while accounting for ...
Increasing cancer incidence rates in younger and older adults worldwide
1. In this surveillance study, the incidence rates of several cancers increased among both younger and older adults in many ...
Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer
1. Progression-free survival and overall survival were significantly greater in the combination therapy group compared to enzalutamide alone. 2. Anemia ...
2 Minute Medicine: Pharma Roundup – Gastric Immunotherapy Gains, Prostate Pill Expansion, Five-Minute Myeloma Dosing, and Streamlined CAR-T Access [July 8th 2025]
Imfinzi Combo Cuts Gastric Cancer Risk by Twenty Nine Percent Earlier this week at the American Society of Clinical Oncology ...
The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Jessie ...
Exercise improves sexual function in men with prostate cancer
1. In this randomized clinical trial, exercise was significantly associated with improved sexual function in men with prostate cancer. 2. ...
Genome classifiers may aid prostate cancer risk stratification and treatment
1. In this systematic review, ten studies reported risk reclassification of prostate cancer with genome classifier testing, with wide variation ...
